pharma-company /Medicinal products /Active ingredients

Rx · PZN 09203035

IRINOTECAN Bendalis 20mg-ml 500mg solution for infusion-concentrate

German trade nameIRINOTECAN Bendalis 20mg-ml 500mg Infusionslösungskonzentrat

Active ingredientIrinotecanPharmaceutical formConcentrate for solution for infusion

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Highest known
purchase price (B2B)

~ €735

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for IRINOTECAN Bendalis 20mg-ml 500mg solution for infusion-concentrate.

Review purchasing terms

IRINOTECAN Bendalis 20mg-ml 500mg solution for infusion-concentrate contains the active ingredient Irinotecan and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 09203035). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


IRINOTECAN Bendalis 20mg-ml 500mg solution for infusion-concentrate was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.